Illumina Shares Surge After Genomics Giant Crushes Quarterly Growth Expectations
The biotechnology sector witnessed a significant shift in momentum this week as Illumina reported financial results that far exceeded the conservative estimates
by 
Josh Weiner
Josh Weiner